🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The use of R-CHOP, given every two weeks, will be associated with improveme...
Status
Completed
Location
USC Norris Comprehensive Cancer Center
Start Date
2008-01-10
Trial ID
NCT00599170
Treatments Being Tested
Previously untreated CD20 positive diffuse large B-cell lymphoma (DLBCL) re...
Status
Completed
Location
Southampton University Hospitals NHS Tust
Start Date
2017-06-02
Trial ID
NCT03571308
Treatments Being Tested
A prospective pilot trial was proposed to patients with DLBCL, with IH or h...
Status
Completed
Location
University Hospital
Start Date
2002-04
Trial ID
NCT00965289
Treatments Being Tested
The study aims to compare two application forms (pre-filled syringe and On-...
Status
Completed
Location
Research Site
Start Date
2018-06-25
Trial ID
NCT03619993
Treatments Being Tested
In the present trial the chemotherapy- light treatment concept R-Pola-Glo w...
Status
Active Not Recruiting
Location
Uniklinik Innsbruck
Start Date
2023-03-20
Trial ID
NCT05798156
Treatments Being Tested
Phase 2 Study of Abbreviated 3 Cycles of Rituximab plus CHOP (Cyclophospham...
Status
Unknown
Location
Multiple Locations
Start Date
2016-12-07
Trial ID
NCT03399747
Treatments Being Tested
Diffuse large B-cell lymphoma is the most prevalent subgroup within maligna...
Status
Completed
Location
Landeskrankenhaus Feldkirch
Start Date
2007-12
Trial ID
NCT00575406
Treatments Being Tested
The purpose of this study is to clarify the impact of rituximab on clinical...
Status
Completed
Location
Chonbuk National University Hospital
Start Date
2011-08
Trial ID
NCT01448096
Treatments Being Tested
Within this exploratory multicohort phase II trial, SAKK aims to evaluate a...
Status
Active Not Recruiting
Location
Ospedale Papa Giovanni XXIII
Start Date
2021-06-25
Trial ID
NCT04604067
Treatments Being Tested
The purpose of this study is to determine the complete response rate when C...
Status
Completed
Location
UPMC Cancer Centers
Start Date
2003-11
Trial ID
NCT00177554
Treatments Being Tested